Menu
24matins.uk
Navigation : 
  • News
    • Business
    • Recipe
    • Sport
  • World
  • Health
  • Culture
  • Tech
    • Science
Currently : 
  • Health
  • Entertainment
  • Tech
  • Recipe

First Human H9N2 Bird Flu Case Detected in Italy, Europe Alert

Health / Health / Italy / Europe
By Newsroom,  published 4 April 2026 at 8h50, updated on 4 April 2026 at 8h50.
Health

ADN

Italy has reported its first human case of H9N2 avian influenza, raising concerns across Europe about the potential spread of this bird flu strain. Health authorities are closely monitoring the situation and assessing possible risks to public health.

TL;DR

  • First human H9N2 case in Europe confirmed in Italy.
  • Virus presents minimal risk to the general population.
  • Surveillance of avian viruses remains crucial, experts stress.

First European Human Case of H9N2 Confirmed in Italy

Health authorities in Italy have confirmed the first-ever European human infection with the H9N2 strain of avian influenza, a development that, while notable, appears to pose minimal risk to public health for now. The case involves a young boy who contracted the virus during a recent visit to Africa, before returning home to Lombardy, northern Italy. Upon his arrival, he was admitted for isolation at the San Gerardo Hospital in Monza. Medical staff report his condition as stable, with no serious symptoms observed.

A Mildly Pathogenic Strain with Limited Human Impact

To put matters into perspective, H9N2 belongs to the expansive group of influenza A viruses—a family that includes well-known strains like H1N1 and H3N2 responsible for seasonal outbreaks, but also many variants predominantly affecting birds. Unlike more virulent forms such as H5N1, H9N2 is categorized as “low pathogenic” among poultry and tends to cause only mild illness in humans. Transmission typically requires prolonged and direct contact with infected animals rather than human-to-human spread.

So far, most documented human cases—several hundred—have been reported across parts of Asia and Africa, particularly in China. This Italian diagnosis marks an unprecedented occurrence within Europe but does not significantly change the overall risk assessment.

Risk Assessment: Why Experts Remain Calm

For now, leading specialists maintain that the public health threat remains extremely low. The Italian health ministry immediately undertook thorough contact tracing efforts around those exposed to the patient; reassuringly, there is no evidence so far of further transmission.

Several factors explain this decision:

  • The adaptation of H9N2 for efficient human infection is not yet observed.
  • No sign suggests it can spread between people at this stage.
  • Other strains like H5N1 present greater concern globally.

The Ongoing Need for Vigilance Against Emerging Viruses

Nevertheless, this isolated incident serves as a timely reminder. As underscored by virologist Ed Hutchinson from the MRC-University of Glasgow Centre for Virus Research, rigorous monitoring of emerging avian influenza viruses remains crucial due to their unpredictable nature. While panic would be premature, staying alert ensures that any potential threat is quickly identified and contained—an approach that continues to underpin global public health strategy amid persistent viral threats.

Le Récap
  • TL;DR
  • First European Human Case of H9N2 Confirmed in Italy
  • A Mildly Pathogenic Strain with Limited Human Impact
  • Risk Assessment: Why Experts Remain Calm
  • The Ongoing Need for Vigilance Against Emerging Viruses
Learn more
  • Prostate Cancer Nighttime Symptoms That Disrupt Men’s Sleep
  • Sun Exposure Risks: Myths About Treating Infant Jaundice Explained
  • Hidden Environmental Impact of Cannabis, Cocaine, and Ecstasy Pollution
  • About Us
© 2026 - All rights reserved on 24matins.uk site content